TrialHuman vaccines & immunotherapeutics2020

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China.

Yuemei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.